Literature DB >> 11739711

Chimeric human immunodeficiency virus type 1 containing murine leukemia virus matrix assembles in murine cells.

Margaret Reed1, Roberto Mariani, Liana Sheppard, Katja Pekrun, Nathaniel R Landau, Nay-Wei Soong.   

Abstract

Murine cells do not support efficient assembly and release of human immunodeficiency virus type 1 (HIV-1) virions. HIV-1-infected mouse cells that express transfected human cyclin T1 synthesize abundant Gag precursor polyprotein, but inefficiently assemble and release virions. This assembly defect may result from a failure of the Gag polyprotein precursor to target to the cell membrane. Plasma membrane targeting of the precursor is mediated by the amino-terminal region of polyprotein. To compensate for the assembly block, we substituted the murine leukemia virus matrix coding sequences into an infectious HIV-1 clone. Transfection of murine fibroblasts expressing cyclin T1 with the chimeric proviruses resulted in viruses that were efficiently assembled and released. Chimeric viruses, in which the cytoplasmic tail of the transmembrane subunit, gp41, was truncated to prevent potential interference between the envelope glycoprotein and the heterologous matrix, could infect human and murine cells. They failed to further replicate in the murine cells, but replicated with delayed kinetics in human MT-4 cells. These findings may be useful for establishing a murine model for HIV-1 replication.

Entities:  

Mesh:

Year:  2002        PMID: 11739711      PMCID: PMC135687          DOI: 10.1128/jvi.76.1.436-443.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions.

Authors:  T Murakami; E O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells.

Authors:  P D Bieniasz; B R Cullen
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 3.  HIV-1 gag proteins: diverse functions in the virus life cycle.

Authors:  E O Freed
Journal:  Virology       Date:  1998-11-10       Impact factor: 3.616

4.  Mouse-human heterokaryons support efficient human immunodeficiency virus type 1 assembly.

Authors:  R Mariani; B A Rasala; G Rutter; K Wiegers; S M Brandt; H G Kräusslich; N R Landau
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production.

Authors:  E O Freed; J M Orenstein; A J Buckler-White; M A Martin
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

6.  Expression of active human immunodeficiency virus type 1 protease by noninfectious chimeric virus particles.

Authors:  N E Kohl; R E Diehl; E Rands; L J Davis; M G Hanobik; B Wolanski; R A Dixon
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

7.  Functional exchange of an oncoretrovirus and a lentivirus matrix protein.

Authors:  C A Deminie; M Emerman
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

8.  Isolation and characterization of a syncytium-inducing, macrophage/T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo.

Authors:  R Shibata; M D Hoggan; C Broscius; G Englund; T S Theodore; A Buckler-White; L O Arthur; Z Israel; A Schultz; H C Lane
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

9.  Incorporation of human immunodeficiency virus type 1 Gag proteins into murine leukemia virus virions.

Authors:  C A Deminie; M Emerman
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

10.  Expression and frameshifting but extremely inefficient proteolytic processing of the HIV-1 gag and pol gene products in stably transfected rodent cell lines.

Authors:  D Moosmayer; H Reil; M Ausmeier; J G Scharf; H Hauser; K D Jentsch; G Hunsmann
Journal:  Virology       Date:  1991-07       Impact factor: 3.616

View more
  21 in total

1.  Analysis of human immunodeficiency virus matrix domain replacements.

Authors:  Isabel Scholz; Amelia Still; Tenzin Choesang Dhenub; Kelsey Coday; Mike Webb; Eric Barklis
Journal:  Virology       Date:  2007-11-08       Impact factor: 3.616

2.  Effect of multimerization on membrane association of Rous sarcoma virus and HIV-1 matrix domain proteins.

Authors:  Robert A Dick; Elena Kamynina; Volker M Vogt
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

3.  Isolation and characterization of mouse-human microcell hybrid cell clones permissive for infectious HIV particle release.

Authors:  Ayse K Coskun; Marc van Maanen; David Janka; David Stockton; Pawel Stankiewicz; Pawel Stankiewicsz; Svetlana Yatsenko; Richard E Sutton
Journal:  Virology       Date:  2007-01-31       Impact factor: 3.616

4.  Matrix-induced inhibition of membrane binding contributes to human immunodeficiency virus type 1 particle assembly defects in murine cells.

Authors:  Theodora Hatziioannou; Juan Martin-Serrano; Trinity Zang; Paul D Bieniasz
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Contribution of virus-like particles to the immunogenicity of human immunodeficiency virus type 1 Gag-derived vaccines in mice.

Authors:  S B Justin Wong; Robert F Siliciano
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  Replication of equine infectious anemia virus in engineered mouse NIH 3T3 cells.

Authors:  Baoshan Zhang; Ronald C Montelaro
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

7.  Human chromosome 2 carries a gene required for production of infectious human immunodeficiency virus type 1.

Authors:  Ayse K Coskun; Marc van Maanen; Van Nguyen; Richard E Sutton
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  Capsid is a dominant determinant of retrovirus infectivity in nondividing cells.

Authors:  Masahiro Yamashita; Michael Emerman
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body.

Authors:  Akira Ono; Eric O Freed
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Matrix mediates the functional link between human immunodeficiency virus type 1 RNA nuclear export elements and the assembly competency of Gag in murine cells.

Authors:  Nathan M Sherer; Chad M Swanson; Stelios Papaioannou; Michael H Malim
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.